Journey Advisory Group, LLC Amgen Inc Transaction History

Journey Advisory Group, LLC

$836 Million
Q2 2024

A detailed history of Journey Advisory Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Journey Advisory Group, LLC holds 26,163 shares of AMGN stock, worth $8.36 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

26,163

Previous 24,966 4.79%

Holding current value

$8.36 Million

Previous $7.1 Million 15.16%

% of portfolio

0.98%

Previous 0.88%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $314,511 - $382,214	1,197 Added 4.79%	26,163 $8.17 Million
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $597,698 - $721,496	2,223 Added 9.77%	24,966 $7.1 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $83,613 - $94,326	327 Added 1.46%	22,743 $6.55 Million
Q3 2023 Nov 15, 2023	BUY	$218.65 - $271.46 $172,952 - $214,724	791 Added 3.66%	22,416 $6.02 Million
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $132,204 - $156,329	617 Added 2.94%	21,625 $4.8 Million
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $905,417 - $1.1 Million	4,010 Added 23.59%	21,008 $5.08 Million
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $1.24 Million - $1.57 Million	5,406 Added 46.64%	16,998 $4.46 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $373,725 - $421,494	1,665 Added 16.77%	11,592 $2.61 Million
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $702,742 - $782,030	3,046 Added 44.27%	9,927 $2.44 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $296,233 - $327,712	1,351 Added 24.43%	6,881 $1.66 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $288,376 - $330,020	1,450 Added 35.54%	5,530 $1.24 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $231,162 - $270,834	1,089 Added 36.41%	4,080 $868,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $145,753 - $161,703	624 Added 26.36%	2,991 $729,000
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $35,061 - $40,858	158 Added 7.15%	2,367 $589,000
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $477,983 - $569,193	2,209 New	2,209 $508,000

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Advisory Group, LLC with notifications on news.

Account

Journey Advisory Group, LLC Amgen Inc Transaction History